Bibliografia UJ CM



Zapytanie: PAPADAKIS V
Liczba odnalezionych rekordów: 7



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/7
P. Berlanga, C. Pasqualini, U. Potschger, C. Sanguesa, M.R. Castellani, A. Can˜ete, R. Luksch, M. Elliot, G. Schreier, M. Kropf, D. Morgenstern, V. Papadakis, S. Ash, E. Ruud, P. Brock, A[leksandra] Wieczorek, P. Kogner, T. Trahair, P. Ambros, T. Boterberg, V. Castel, D. Valteau-Couanet, R. Ladenstein.
Central nervous system relapse in high-risk stage 4 neuroblastoma : The HR-NBL1/SIOPEN trial experience.
European Journal of Cancer
2021 : Vol. 144, s. 1-8, il., bibliogr. 17 poz., abstr.
Autor korespondencyjny: P. Berlanga.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0959-8049
AZ
ORG
AIF
IF: 10.002
Adres url:
Streszczenie w PubMed:
2/7
Y. Matser, I. Verly, M. De Sain-Van Der Velden, A[leksandra] Wieczorek, A. Vicha, S. Ash, C. Pasqualini, M. Beck-Popovic, G. Schleiermacher, A. Canete, C. Owens, I. Ora, B. De Wilde, G. Cangemi, A. Garaventa, E. Grouzmann, V. Papadakis, T. Simon, B. Hero, A. Van Kuilenburg, G. Tytgat.
Optimising Urinary Catecholamine Diagnostics for Neuroblastoma Patients.
Pediatric Blood & Cancer
2020 : Vol. 67, suppl. 4, s. S278, abstr. 0616
Abstracts from the 52th Congress of the International Society of Paediatric Oncology (SIOP) Virtual Congress, October 14-17, 2020.
p-ISSN: 1545-5009
SZZ
SIF
Adres url:
3/7
R. Ladenstein, U. Poetschger, T. Boterberg, K. Dieckmann, S. Bolle, K. Holmes, S. Sarnacki, J. Gomez-Chacon, P. Brock, R. Luksch, S. Ash, W[alentyna] Balwierz, E. Ruud, V. Papadakis, C. Owens, J. Stenman, H. Schroeder, T. Trahair, D. Valteau-Couanet, M. Gaze.
Success of the HR-NBL1/SIOPEN Trial Local Control Strategy in High-Risk Neuroblastoma Patients Receiving High-Dose Therapy and Stem Cell Transplantation.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S261-S262, abstr. PO-372.
p-ISSN: 1545-5009
SZZ
SIF
4/7
R. Ladenstein, U. Poetschger, S. Sarnacki, T. Monclair, G. Cecchetto, J. Gomez-Chacon, J. Stenman, J.M. Joseph, R. Luksch, V. Castel, S. Ash, V. Papadakis, J. Malis, W[alentyna] Balwierz, C. Owens, H. Lode, T. Boterberg, D. Valteau-Couanet, A.D. Pearson, K. Holmes.
The Influence of Surgical Excision on Survival in High-Risk Neuroblastoma Revisited After Introduction of ch14.18/CHO Immunotherapy in the HR-NBL1/SIOPEN Trial.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S36-S37, abstr. O-062.
p-ISSN: 1545-5009
SZZ
SIF
5/7
R. Ladenstein, U. Poetschger, D. Valteau-Couanet, V. Castel, M. Elliott, S. Ash, G. Chan, G. Laureys, M. Beck-Popovic, K. Vettenranta, W[alentyna] Balwierz, H. Schroeder, C. Owens, M. Cesen, V. Papadakis, T. Trahair, R. Luksch, G. Schleiermacher, P. Ambros, A. Garaventa.
The Randomised Induction for High-Risk Neuroblastoma Comparing COJEC and N5-MSKCC Regimens. Early Results from the HR-NBL1.5/SIOPEN Trial.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S11, abstr. O-013.
p-ISSN: 1545-5009
SZZ
SIF
6/7
R. Ladenstein, U. Poetschger, P. Brock, R. Luksch, V. Castel, I. Yaniv, V. Papadakis, G. Laureys, J. Malis, W[alentyna] Balwierz, P. Kogner, P. Ambros, K. Holmes, M. Gaze, G. Schreier, A. Garaventa, G. Vassal, J. Michon, A. Pearson, D. Valteau-Couanet.
Long-Term Results for Children with High-Risk Neuroblastoma Treated on the Randomized High-Dose Therapy Trial of Busulphan-Melphalan Versus Carboplatin-Etoposide-Melphalan: A Siopen Study.
Pediatric Blood & Cancer
2016 : Vol. 63, Suppl. 3, s. S32, abstr. O-106.
48th Congress of the International Society of Paediatric Oncology (SIOP) Dublin, Ireland, October 19-22, 2016.
p-ISSN: 1545-5009
SZZ
SIF
7/7
R. Ladenstein, U. Poetschger, M. Elliot, R. Luksch, V. Castel, I. Yaniv, V. Papadakis, G. Laureys, J. Malis, W[alentyna] Balwierz, E. Ruud, P. Kogner, H. Schroeder, A. Forjaz de Lacerda, M. Beck-Popovic, P. Bician, M. Garami, T. Trahair, P. Ambros, K. Holmes, G. Schreier, M. Gaze, A. Pearson, D. Valteau-Couanet, SIOP Europe Neuroblastoma Grp.
Risk factors in stage 4 neuroblastoma patients treated with Busulphan-Melphalan. Report from the European High Risk Neuroblastoma HR-NBL1/SIOPEN TRIAL.
Bone Marrow Transplantation
2016 : Vol. 51, suppl. 1, s. S46, abstr. O072.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, APR 03-06, 2016.
p-ISSN: 0268-3369
SZZ
SIF
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ